Viridian Therapeutics Inc (1S1) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	70.57M	132.00K	141.00K	284.00K
Cost of goods sold	86.26M	92.71M	77.63M	71.58M
Cost of revenue	86.26M	92.71M	77.63M	71.58M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	24.32M	33.67M	38.68M	54.98M
Operating expense	24.32M	33.67M	38.68M	54.98M
Total operating expenses	110.58M	126.38M	116.31M	126.55M
Operating income	-40.01M	-126.25M	-116.17M	-126.27M
Other non operating income	453.00K	-2.12M	6.86M	-1.03M
EBT including unusual items	-34.60M	-120.36M	-104.90M	-127.12M
EBT excluding unusual items	-34.60M	-123.86M	-104.90M	-127.12M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-34.60M	-120.36M	-104.90M	-127.12M
Net profit margin	-49.03%	-91,178.03%	-74,397.87%	-44,760.21%
Earnings per share	-0.34	-1.08	-0.90	-1.05
Interest and investment income	5.52M	7.79M	7.87M	8.49M
Interest expense	-560.00K	-3.28M	-3.46M	-8.31M
Net interest expenses	4.96M	4.51M	4.41M	183.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-39.90M	-126.13M	-116.05M	-126.15M
Gain or loss from assets sale	-	-	-	-

Ask anything